DAX25.105 +0,1%Est506.051 -0,1%MSCI World4.343 -0,1%Top 10 Crypto9,3400 -0,4%Nas26.973 +0,2%Bitcoin63.293 +0,6%Euro1,1660 ±0,0%Öl92,05 -1,4%Gold4.542 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Infineon 623100 NVIDIA 918422 Rheinmetall 703000 Microsoft 870747 Siemens Energy ENER6Y SAP 716460 Micron Technology 869020 Dell Technologies A2N6WP Lufthansa 823212 NEL ASA A0B733 Deutsche Telekom 555750 AMD (Advanced Micro Devices) 863186 RENK RENK73 Amazon 906866 Münchener Rückversicherungs-Gesellschaft 843002
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen erzielen neue Rekorde -- USA und Iran wohl vor Einigung: DAX geht stabil ins Wochenende -- Dell von KI-Boom beflügelt -- Siemens Energy, Eli Lilly, IBM, Eventim, DHL im Fokus
Top News
Rüstungsaktien im Realitätscheck: die Analyse nach dem Kursrutsch Rüstungsaktien im Realitätscheck: die Analyse nach dem Kursrutsch
NBER-Studie offenbart Investitionsstrategie der Millionäre NBER-Studie offenbart Investitionsstrategie der Millionäre
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Abbott Laboratories Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
73,22 EUR -1,05 EUR -1,41 %
BMN
85,60 USD +0,01 USD +0,01 %
nachbörslich
BTT
finanzen.net zero
Abbott Laboratories jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.128,92 Mrd. EUR

KGV33,69Div. Rendite1,92%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN850103

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS0028241000

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolABT

Abbott Laboratories Aktien News

DatumMeistgelesen
PR NewswireAbbott's FreeStyle Libre 3 Plus Now Covered Across Canada
PR NewswireAbbott hosts conference call for fourth-quarter earnings
PR NewswireAbbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
Wer­bungAbbott Laboratories-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireAbbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
PR NewswireAbbott increases quarterly dividend for 54th consecutive year
PR NewswireAbbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
PR NewswireUniversity of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
PR NewswireMuscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
PR NewswireAbbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
PR NewswireAbbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
PR NewswireAbbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
PR NewswireAbbott Hosts Conference Call for Third-Quarter Earnings
PR NewswireAbbott Declares 407th Consecutive Quarterly Dividend
PR NewswireAbbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
PR NewswireNYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
PR NewswireAbbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
PR NewswireAbbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
PR NewswireAbbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
PR NewswireAbbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
PR NewswireAbbott Hosts Conference Call for Second-Quarter Earnings
PR NewswireNew Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
PR NewswireAbbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions
PR NewswireAbbott Declares 406th Consecutive Quarterly Dividend
PR NewswireAbbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
PR NewswireAbbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
PR NewswireMotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
PR NewswireAbbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
PR NewswireCIBC introduces additional U.S. Canadian Depositary Receipts ("CDRs")
PR NewswireCIBC introduces additional U.S. Canadian Depositary Receipts ("CDRs")
PR NewswireAbbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
PR NewswireNew Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
PR NewswireNew Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
PR NewswireAbbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
PR NewswireNew Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve
PR NewswireAbbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Hosts Conference Call for First-Quarter Earnings

Abbott Laboratories News

Abbott Laboratories News: auf dieser Seite finden Sie alle Abbott Laboratories News und Nachrichten zur Abbott Laboratories Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Abbott Laboratories News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Abbott Laboratories News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.